Last reviewed · How we verify

NCT04994834

Characterization of the Gastrointestinal Microbiota in Term Newborn Infants After 4 Weeks Supplementation of Probiotics

Completed NA Last updated 12 July 2022
What this trial tests

NA trial testing Probiotics in Gut Microbiota in 22 participants. Completed in 1 June 2022.

Timeline
15 July 2021
Primary endpoint
30 March 2022
1 June 2022

Quick facts

Lead sponsorChr Hansen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment22
Start date15 July 2021
Primary completion30 March 2022
Estimated completion1 June 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Chr Hansen — full company profile →

Who can join

Adults 0 Days to 2 Months, any sex, with Gut Microbiota. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A mono center, open label, pilot study in term newborn infants. The study will investigate the effect of supplementation with probiotics on the presence of total Bifidobacterium in the infant feces.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Seeding the Infant Gut in Early Life-Effects of Maternal and Infant Seeding with Probiotics on Strain Transfer, Microbiota, and Gastrointestinal Symptoms in Healthy Breastfed Infants.
    Melsaether C, Høtoft D, Wellejus A, Hermes GDA, et al · · 2023 · cited 5× · PMID 37764787 · DOI 10.3390/nu15184000

Verify or expand the search:

Other trials of Probiotics

Trials testing the same drug.

Other recruiting trials for Gut Microbiota

Currently open trials in the same condition.

Other Chr Hansen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04994834.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing